← SynDRA

SOFOSBUVIR

SynDRA canonical compound SYN0024773 — structure-anchored drug synonym record

All known targets

• HCV NS5B
• NS5B

Mechanisms of action (all sources)

• HCV inhibitor
• Modulator
• NS5B INHIBITOR

Drug classes

• Anti-Infective Agents
• Antiviral Agents
• RNA Replicase Inhibitors
• Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor

ATC classes

• J05A · DIRECT ACTING ANTIVIRALS

Cross-references

• PubChem CID: 45375808
• ChEMBL: CHEMBL1259059
• DrugBank: DB08934
• ChEBI: CHEBI:85083
• KEGG: D10366
• RxNorm: 1484911
• PDB: WG6
• Wikipedia: Sofosbuvir
• TTD: D0D4YZ

Synonyms

• sovaldi
• PSI-7977
• GS-7977
• GS7977
• Psi-7977, gs-7977
• Sofosbuvir component of epclusa
• Sofosbuvir component of harvoni
• Sofosbuvir component of vosevi
• Sovaldi
• PSI 7977
• SOVALDI
• GS 7977
• UNII-WJ6CA3ZU8B
• WJ6CA3ZU8B
• CHEBI:85083
• Sofosbuvir (PSI-7977, GS-7977)
• Hepcvir
• Hepcinat
• HSDB 8226
• 2-((5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy)phenoxyphosphorylamino)propionic acid isopropyl ester
• Sofosbuvir [USAN:INN]
• Resof
• SoviHep
• Sovaldi (TN)
• Sofosbuvir (JAN/USAN)
• Sofosbuvir(PSI-7977)
• GTPL7368
• SCHEMBL2010114
• CHEMBL1259059
• AMMD00019
• EX-A389
• MolPort-028-720-482
• isopropyl (2S)-2-[[[(2R,
• VOSEVI COMPONENT SOFOSBUVIR
• sof
• HARVONI COMPONENT SOFOSBUVIR
• EPCLUSA COMPONENT SOFOSBUVIR
• PSI7977

Reported adverse events

• Bradycardia
• Angioedema
• Irritability
• Depression
• Asthenia
• Fatigue
• Headache
• Insomnia
• Nausea
• Rash
• Myalgia
• Vomiting